Nika Pharmaceuticals annual working capital
2021
2022
2023
2024
2025
Nika Pharmaceuticals Working Capital Growth & History (NIKA)
Nika Pharmaceuticals's working capital was −$297,628 for fiscal 2025.
View full Nika Pharmaceuticals company overviewNika Pharmaceuticals annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$297,628 | −$76,398 | — |
| 2024 | 2024-12-31 | −$221,230 | −$139,081 | — |
| 2023 | 2023-12-31 | −$82,149 | −$64,833 | — |
| 2022 | 2022-12-31 | −$17,316 | −$7,197 | — |
| 2021 | 2021-12-31 | −$10,119 | — | — |
Nika Pharmaceuticals quarterly working capital
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$330,682 | −$78,125 | — |
| Q1 2026 | 2026-03-31 | −$310,987 | −$76,811 | — |
| Q4 2025 | 2025-12-31 | −$297,628 | −$76,398 | — |
| Q3 2025 | 2025-09-30 | −$260,539 | −$51,761 | — |
| Q2 2025 | 2025-06-30 | −$252,557 | $162,314 | — |
| Q1 2025 | 2025-03-31 | −$234,176 | −$9,694 | — |
| Q4 2024 | 2024-12-31 | −$221,230 | −$139,081 | — |
| Q3 2024 | 2024-09-30 | −$208,778 | −$133,943 | — |
| Q2 2024 | 2024-06-30 | −$414,871 | — | — |
| Q1 2024 | 2024-03-31 | −$224,482 | −$187,596 | — |
| Q4 2023 | 2023-12-31 | −$82,149 | −$64,833 | — |
| Q3 2023 | 2023-09-30 | −$74,835 | −$72,569 | — |
| Q1 2023 | 2023-03-31 | −$36,886 | — | — |
| Q4 2022 | 2022-12-31 | −$17,316 | −$7,197 | — |
| Q3 2022 | 2022-09-30 | −$2,266 | — | — |
| Q2 2022 | 2022-06-30 | $4,073 | — | — |
| Q4 2021 | 2021-12-31 | −$10,119 | — | — |
Nika Pharmaceuticals working capital trends
Between the periods ended 2021-12-31 and 2025-12-31, Nika Pharmaceuticals's working capital decreased from −$10,119 to −$297,628, a change of −$287,509. The latest reported quarter, Q2 2026, shows −$330,682.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nika Pharmaceuticals source filings ↗